In Conversation

"The ultimate goal of our investment is to license the production and commercialization of our products to pharmaceutical companies."

"Serbia has such agreements and tax laws with the EU allowing us to import and export goods without paying customs."

"Phytobios is responsible for the tough task of organising the expeditions to the Amazon and Atlantic forest and also to the Brazilian savannah for data and…

"Expanding on other interesting trends, it is a reality that more and more companies are willing to launch their products to the Baltic region and Lithuania,…

"We want stakeholders to know that we are a leading company in diabetes – this is the core of our business."

"I believe that Brazilians should take pride on our public health system, especially given that it covers over 208 million inhabitants."

"The purpose behind the creation of Biognosys was to better understand the mode of action of various drugs and biological processes by understanding the changes in…

"Not only did Roche not reconsider its investment approach to Brazil, but we actually increased our commitment to the country over the past few years."

"India is a land of opportunities and if you do business in the right way you can shape the market and grow significantly."

"Every year the number of innovative products entering the market is improving, despite our government placing pricing pressures on companies to lower the costs of treatment."

"As one of the world’s leading innovative companies, we have also broadened our R&D approach to Brazil by trying to more directly support local innovative projects,…

"The constant obstacle our clients are witnessing is the pricing pressures being placed upon them from the payers - the Ministry of Health and National health…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here